Outlook Wealth Advisors’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-4,418
Closed -$226K 195
2022
Q4
$226K Buy
+4,418
New +$212K 0.11% 159
2022
Q3
Sell
-4,367
Closed -$229K 196
2022
Q2
$229K Sell
4,367
-158
-3% -$8.05K 0.09% 174
2022
Q1
$234K Buy
4,525
+63
+1% +$3.27K 0.08% 181
2021
Q4
$263K Sell
4,462
-439
-9% -$21.8K 0.08% 178
2021
Q3
$211K Sell
4,901
-228
-4% -$10.1K 0.07% 201
2021
Q2
$201K Buy
+5,129
New +$199K 0.06% 205
2021
Q1
Sell
-7,029
Closed -$259K 197
2020
Q4
$259K Sell
7,029
-1,809
-20% -$66.4K 0.09% 166
2020
Q3
$308K Buy
8,838
+984
+13% +$34.5K 0.12% 146
2020
Q2
$244K Sell
7,854
-1,238
-14% -$42.1K 0.1% 150
2020
Q1
$282K Sell
9,092
-2,111
-19% -$71.9K 0.16% 128
2019
Q4
$416K Sell
11,203
-540
-5% -$19.2K 0.23% 85
2019
Q3
$400K Buy
11,743
+6,727
+134% +$245K 0.24% 93
2019
Q2
$206K Buy
+5,016
New +$199K 0.14% 144
2019
Q1
Sell
-1,321
Closed -$547K 172
2018
Q4
$547K Buy
+1,321
New +$54.8K 0.25% 99

Other funds holding PFE

Outlook Wealth Advisors's PFE Position: Q1 2023 in Review

Outlook Wealth Advisors sold out of Pfizer (PFE) in Q1 2023, closing a stake of 4,418 shares — an estimated $226K sold.

Outlook Wealth Advisors first reported a position in PFE in Q4 2018 and held it in 14 quarters. The position peaked at $547K in Q4 2018. 3,102 funds tracked by Wall St. Rank hold PFE as of Q1 2023.

  • Outlook Wealth Advisors reported no remaining Pfizer position as of Q1 2023 after selling out during the quarter.
  • Outlook Wealth Advisors sold 4,418 Pfizer shares in Q1 2023, an estimated $226K.
  • Outlook Wealth Advisors first reported a position in Pfizer in Q4 2018 and held it in 14 quarters.
  • Outlook Wealth Advisors's Pfizer position peaked at $547K in Q4 2018.
  • 3,102 funds tracked by Wall St. Rank held Pfizer as of Q1 2023.

Based on Outlook Wealth Advisors's 13F filing for Q1 2023, filed 18 Apr 2023.